Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 6/20 | 0.70 |
| ▸ | DAO | P14920 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.70 |
| ▸ | IDH1 | O75874 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Kojic Acid SCHEMBL27429993 | 0.86 | TYR (0.88) | TYRDAOKDM4EIDH1 | |
| Kojic Acid SCHEMBL28279558 | 0.83 | TYR (0.92) | TYRDAOKDM4EIDH1 | |
| Kojic Acid SCHEMBL5011817 | 0.83 | TYR (1.00) | TYRDAOKDM4EIDH1 | |
| Kojic Acid SCHEMBL36895 | 0.83 | TYR (1.00) | TYRDAOKDM4EIDH1 | |
| Kojic Acid SCHEMBL28491069 | 0.81 | TYR (0.96) | TYRDAOKDM4EIDH1 | |
| Kojic Acid SCHEMBL28650749 | 0.81 | TYR (0.96) | TYRDAOKDM4EIDH1 | |
| Kojic Acid SCHEMBL12538255 | 0.81 | TYR (0.96) | TYRDAOKDM4EIDH1 | |
| Kojic Acid SCHEMBL6786872 | 0.81 | TYR (0.96) | TYRDAOKDM4EIDH1 | |
| Kojic Acid SCHEMBL28654757 | 0.81 | TYR (0.96) | TYRDAOKDM4EIDH1 | |
| Kojic Acid SCHEMBL28808848 | 0.81 | TYR (0.96) | TYRDAOKDM4EIDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2025-05-22 | — | — | US | claimed |
| EP-4469037-A1 | ANTIMICROBIAL COMPOSITIONS | Bio-Actives Synergio Ltd (IL) | 2024-12-04 | — | — | EP | claimed |
| CN-118660702-A | Antimicrobial compositions | 生物活性协同有限公司 | 2024-09-17 | — | — | CN | claimed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | claimed |
| US-4279936-A | Maltol treated canned meat process | WILLIAM UNDERWOOD COMPANY (US) | 1981-07-21 | — | — | US | claimed |
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2025-05-22 | — | — | US | disclosed |
| EP-4469037-A1 | ANTIMICROBIAL COMPOSITIONS | Bio-Actives Synergio Ltd (IL) | 2024-12-04 | — | — | EP | disclosed |
| CN-118660702-A | Antimicrobial compositions | 生物活性协同有限公司 | 2024-09-17 | — | — | CN | disclosed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | disclosed |
| WO-2022189856-A9 | COMPOUNDS USEFUL FOR TREATING LIVER DISEASES | ABIONYX PHARMA SA (FR) | 2022-10-13 | — | — | WO | disclosed |
| US-20180155365-A1 | TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2018-06-07 | — | — | US | disclosed |
| US-20170066754-A1 | ANTIVIRAL AGENT | SHIONOGI & CO., LTD. (JP) | 2017-03-09 | — | — | US | disclosed |
| US-20120014894-A1 | Compositions and Methods for Treating Hyperpigmentation | REVANCE THERAPEUTICS, INC. (US) | 2012-01-19 | — | — | US | disclosed |
| US-20090216014-A1 | NOVEL COMPOUNDS AND METHODS OF TREATING CELL PROLIFERATIVE DISEASES, RETINOPATHIES AND ARTHRITIS | EXONHIT THERAPEUTICS SA (FR) | 2009-08-27 | — | — | US | disclosed |
| US-7514432-B2 | Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis | EXONHIT THERAPEUTICS SA (FR) | 2009-04-07 | — | — | US | disclosed |
| US-20080279794-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | BASCHONG WERNER | 2008-11-13 | — | — | US | disclosed |
| US-20080260667-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | BASCHONG WERNER | 2008-10-23 | — | — | US | disclosed |
| US-7425320-B2 | Use of guaiol for treating the skin | CIBA SPECIALTY CHEMICALS CORP (US) | 2008-09-16 | — | — | US | disclosed |
| US-20070219275-A1 | Use of Benzophenone Uv Filters for Preventing Tanning | BASCHONG WERNER | 2007-09-20 | — | — | US | disclosed |
| WO-2007093880-A2 | NOVEL PYRONE-INDOLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | NEURIM PHARMACEUTICALS (1991) LTD. (US) | 2007-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180155365-A1 | TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS | TYMP, TK1, CDKN1A | TYR 3046/4885DAO 2236/4885KDM4E 1527/4885 |
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | NOD2, PYCARD, CLPP | TYR 1274/4885DAO 3183/4885KDM4E 4332/4885 |
| US-20120014894-A1 | Compositions and Methods for Treating Hyperpigmentation | TYR, CUTA, SLC25A21 | TYR 1/4885DAO 794/4885KDM4E 1221/4885 |
| US-20070219275-A1 | Use of Benzophenone Uv Filters for Preventing Tanning | C1R, CBR3, AOC3 | TYR 18/4885DAO 2243/4885KDM4E 322/4885 |
| US-20090216014-A1 | NOVEL COMPOUNDS AND METHODS OF TREATING CELL PROLIFERATIVE DISEASES, RETINOPATHIES AND ARTHRITIS | RB1, ALDH1A2, CDK4 | TYR 421/4885DAO 4494/4885KDM4E 2345/4885 |
| US-20080260667-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | TYR 2/4885DAO 1178/4885KDM4E 1289/4885 |
| US-20170066754-A1 | ANTIVIRAL AGENT | ZC3HAV1, ZC3HAV1L, CCNI | TYR 2678/4885DAO 347/4885KDM4E 382/4885 |
| US-20080279794-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | TYR 2/4885DAO 1178/4885KDM4E 1289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.